Fox Chase Cancer Center Researchers Propose a New Type of Sarcoma, PHF1::TFE3-Positive Fibromyxoid Sarcoma
“We don’t think it’s the same thing,” said Wei, who conducted the study with colleagues from Fox Chase and researchers from other institutions. “The molecular alteration is different, the morphology is different, and the clinical behavior is different. It’s a different tumor.”